Wimo A

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (11)

Title : The use of cholinesterase inhibitors and the risk of myocardial infarction and death: a nationwide cohort study in subjects with Alzheimer's disease - Nordstrom_2013_Eur.Heart.J_34_2585
Author(s) : Nordstrom P , Religa D , Wimo A , Winblad B , Eriksdotter M
Ref : Eur Heart J , 34 :2585 , 2013
Abstract : Nordstrom_2013_Eur.Heart.J_34_2585
ESTHER : Nordstrom_2013_Eur.Heart.J_34_2585
PubMedSearch : Nordstrom_2013_Eur.Heart.J_34_2585
PubMedID: 23735859

Title : Practical lessons from amyloid immunotherapy trials in Alzheimer disease - Solomon_2012_Curr.Alzheimer.Res_9_1126
Author(s) : Solomon A , Akenine U , Andreasen N , Mangialasche F , Wimo A , Jelic V , Kivipelto M , Winblad B
Ref : Curr Alzheimer Res , 9 :1126 , 2012
Abstract : Solomon_2012_Curr.Alzheimer.Res_9_1126
ESTHER : Solomon_2012_Curr.Alzheimer.Res_9_1126
PubMedSearch : Solomon_2012_Curr.Alzheimer.Res_9_1126
PubMedID: 22631442

Title : Cost effectiveness of cholinesterase inhibitors in the treatment of Alzheimer's disease: a review with methodological considerations - Wimo_2004_Drugs.Aging_21_279
Author(s) : Wimo A
Ref : Drugs & Aging , 21 :279 , 2004
Abstract : Wimo_2004_Drugs.Aging_21_279
ESTHER : Wimo_2004_Drugs.Aging_21_279
PubMedSearch : Wimo_2004_Drugs.Aging_21_279
PubMedID: 15040756

Title : An economic evaluation of donepezil in mild to moderate Alzheimer's disease: results of a 1-year, double-blind, randomized trial - Wimo_2003_Dement.Geriatr.Cogn.Disord_15_44
Author(s) : Wimo A , Winblad B , Engedal K , Soininen H , Verhey F , Waldemar G , Wetterholm AL , Mastey V , Haglund A , Zhang R , Miceli R , Chin W , Subbiah P
Ref : Dementia & Geriatric Cognitive Disorders , 15 :44 , 2003
Abstract : Wimo_2003_Dement.Geriatr.Cogn.Disord_15_44
ESTHER : Wimo_2003_Dement.Geriatr.Cogn.Disord_15_44
PubMedSearch : Wimo_2003_Dement.Geriatr.Cogn.Disord_15_44
PubMedID: 12457078

Title : Assessment of Health Economics in Alzheimer's Disease (AHEAD): Treatment with Galantamine in Sweden - Garfield_2002_Pharmacoeconomics_20_629
Author(s) : Garfield FB , Getsios D , Caro JJ , Wimo A , Winblad B
Ref : Pharmacoeconomics , 20 :629 , 2002
Abstract : Garfield_2002_Pharmacoeconomics_20_629
ESTHER : Garfield_2002_Pharmacoeconomics_20_629
PubMedSearch : Garfield_2002_Pharmacoeconomics_20_629
PubMedID: 12141890

Title : A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD - Winblad_2001_Neurology_57_489
Author(s) : Winblad B , Engedal K , Soininen H , Verhey F , Waldemar G , Wimo A , Wetterholm AL , Zhang R , Haglund A , Subbiah P
Ref : Neurology , 57 :489 , 2001
Abstract : Winblad_2001_Neurology_57_489
ESTHER : Winblad_2001_Neurology_57_489
PubMedSearch : Winblad_2001_Neurology_57_489
PubMedID: 11502918

Title : Assessing the societal impact of acetylcholinesterase inhibitor therapies - Winblad_1999_Alzheimer.Dis.Assoc.Disord_13 Suppl 2_S9
Author(s) : Winblad B , Wimo A
Ref : Alzheimer Disease & Associated Disorders , 13 Suppl 2 :S9 , 1999
Abstract : Winblad_1999_Alzheimer.Dis.Assoc.Disord_13 Suppl 2_S9
ESTHER : Winblad_1999_Alzheimer.Dis.Assoc.Disord_13 Suppl 2_S9
PubMedSearch : Winblad_1999_Alzheimer.Dis.Assoc.Disord_13 Suppl 2_S9
PubMedID: 10622674

Title : The cost-effectiveness of donepezil therapy in Swedish patients with Alzheimer's disease: a Markov model - Jonsson_1999_Clin.Ther_21_1230
Author(s) : Jonsson L , Lindgren P , Wimo A , Jonsson B , Winblad B
Ref : Clin Ther , 21 :1230 , 1999
Abstract : Jonsson_1999_Clin.Ther_21_1230
ESTHER : Jonsson_1999_Clin.Ther_21_1230
PubMedSearch : Jonsson_1999_Clin.Ther_21_1230
PubMedID: 10463520

Title : First International Pharmacoeconomic Conference on Alzheimer's Disease: report and summary - Whitehouse_1998_Alzheimer.Dis.Assoc.Disord_12_266
Author(s) : Whitehouse PJ , Winblad B , Shostak D , Bhattacharjya A , Brod M , Brodaty H , Dor A , Feldman H , Forette F , Gauthier S , Hay J , Henke C , Hill S , Mastey V , Neumann P , O'Brien B , Pugner K , Sano M , Sawada T , Stone R , Wimo A
Ref : Alzheimer Disease & Associated Disorders , 12 :266 , 1998
Abstract : Whitehouse_1998_Alzheimer.Dis.Assoc.Disord_12_266
ESTHER : Whitehouse_1998_Alzheimer.Dis.Assoc.Disord_12_266
PubMedSearch : Whitehouse_1998_Alzheimer.Dis.Assoc.Disord_12_266
PubMedID: 9876955

Title : Treatment of Alzheimer disease with tacrine: a cost-analysis model - Wimo_1997_Alzheimer.Dis.Assoc.Disord_11_191
Author(s) : Wimo A , Karlsson G , Nordberg A , Winblad B
Ref : Alzheimer Disease & Associated Disorders , 11 :191 , 1997
Abstract : Wimo_1997_Alzheimer.Dis.Assoc.Disord_11_191
ESTHER : Wimo_1997_Alzheimer.Dis.Assoc.Disord_11_191
PubMedSearch : Wimo_1997_Alzheimer.Dis.Assoc.Disord_11_191
PubMedID: 9437436

Title : [More accurate diagnosis could identify patients suitable for tacrine therapy] -
Author(s) : Andreasen N , Eriksson S , Karlsson I , Lindahl B , Lund M , Nordberg A , Wimo A , Winblad B , Astrand R
Ref : Lakartidningen , 93 :1200 , 1996
PubMedID: 8656831